预测儿童溃疡性结肠炎的并发症:一项纵向多中心队列研究
研究纳入德国-奥地利CEDATA-GPGE多中心注册库中743例18岁以下溃疡性结肠炎患者,采用Cox回归、Kaplan-Meier估计和ROC曲线分析不良结局的预测因素。诊断时年龄较大与复发、住院、使用免疫调节剂、使用生物制剂及治疗升级相关;前3个月内急性重症结肠炎与后续急性重症结肠炎及需使用生物制剂显著相关;上消化道受累是需静脉使用糖皮质激素和生物制剂的危险因素;粪便钙卫蛋白>685 μg/g与后续急性重症结肠炎风险较高相关(敏感度79.0%,特异度59.1%);诊断时较低的红细胞压积可预测生物制剂的使用;结肠切除术罕见。
要点
- 诊断时年龄较大与复发、住院、使用免疫调节剂、使用生物制剂及治疗升级相关。
- 前3个月内急性重症结肠炎与后续急性重症结肠炎及需使用生物制剂显著相关。
- 粪便钙卫蛋白>685 μg/g与后续急性重症结肠炎风险较高相关,敏感度79.0%、特异度59.1%。
核心结论
- 本研究验证了儿童溃疡性结肠炎患者不良结局的预测因素,结果可能有助于医生预判不良结局并在早期启动适当的治疗策略。
研究设计与样本
- 纵向多中心队列研究,纳入德国-奥地利CEDATA-GPGE注册库中743例18岁以下溃疡性结肠炎患者,采用Cox回归、Kaplan-Meier估计和ROC曲线分析不良结局的预测因素。
主要发现
- 诊断时年龄较大与复发、住院、使用免疫调节剂、使用生物制剂及治疗升级相关。
- 前3个月内急性重症结肠炎与后续急性重症结肠炎及需使用生物制剂显著相关。
- 上消化道受累是需静脉使用糖皮质激素和生物制剂的危险因素。
- 粪便钙卫蛋白>685 μg/g与后续急性重症结肠炎风险较高相关,敏感度79.0%、特异度59.1%。
- 诊断时较低的红细胞压积可预测生物制剂的使用;结肠切除术罕见。
关键数值与推荐
- 粪便钙卫蛋白>685 μg/g与后续急性重症结肠炎风险较高相关,敏感度79.0%、特异度59.1%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To prevent complications of paediatric ulcerative colitis (UC), it is critical to understand their predictors. The Paediatric Inflammatory Bowel Disease Ahead (PIBD Ahead) program identified the relevant outcomes and their potential predictors. However, external validation of these results in larger cohorts is required. AIMS: The aim of this study is to investigate these outcomes and their predictors. METHODS: We included 743 patients aged under 18 years with UC from the multicentre German-Austrian CEDATA-GPGE registry. We performed Cox regressions, Kaplan-Meier estimator, and receiver operating characteristics curve analyses to analyse predictors of poor outcomes. RESULTS: Older age at diagnosis was associated with relapse, hospitalisation, the use of immunomodulators, use of biologics, and therapy escalation. Higher disease activity, as in acute severe colitis in the first 3 months, was significantly associated with further acute severe colitis and the need for biologics. Upper gastrointestinal tract involvement was a risk factor for the need of intravenous corticosteroids and biologics. A faecal calprotectin of >685 μg/g was associated with a higher risk of subsequent acute severe colitis with a sensitivity of 79.0% and a specificity of 59.1%. A lower haematocrit at diagnosis was predictive of the use of biologics. Colectomy was rare. CONCLUSIONS: This study validates predictors of poor outcomes in paediatric patients with UC. Our results might help physicians to anticipate poor outcomes and initiate appropriate treatment strategies at an early stage.
引用
- Claßen M, Schiller B, Däbritz J, et al. Predicting complications in paediatric ulcerative colitis: A longitudinal multicentre cohort study. Aliment Pharmacol Ther. 2024. PMID: 39485058. doi:10.1111/apt.18262
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。